BEIGF
Price
$15.95
Change
-$3.06 (-16.10%)
Updated
Apr 9 closing price
Capitalization
39.21B
CING
Price
$3.87
Change
+$0.08 (+2.11%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
21.11M
Interact to see
Advertisement

BEIGF vs CING

Header iconBEIGF vs CING Comparison
Open Charts BEIGF vs CINGBanner chart's image
BeOne Medicines
Price$15.95
Change-$3.06 (-16.10%)
Volume$100
Capitalization39.21B
Cingulate
Price$3.87
Change+$0.08 (+2.11%)
Volume$400
Capitalization21.11M
BEIGF vs CING Comparison Chart in %
Loading...
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEIGF vs. CING commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEIGF is a Hold and CING is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BEIGF: $15.95 vs. CING: $3.79)
Brand notoriety: BEIGF and CING are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEIGF: 100% vs. CING: 53%
Market capitalization -- BEIGF: $39.21B vs. CING: $21.11M
BEIGF [@Biotechnology] is valued at $39.21B. CING’s [@Biotechnology] market capitalization is $21.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEIGF’s FA Score shows that 0 FA rating(s) are green whileCING’s FA Score has 0 green FA rating(s).

  • BEIGF’s FA Score: 0 green, 5 red.
  • CING’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEIGF and CING are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 4 TA indicator(s) are bullish.

  • CING’s TA Score: 4 bullish, 6 bearish.

Price Growth

BEIGF (@Biotechnology) experienced а 0.00% price change this week, while CING (@Biotechnology) price change was -3.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEIGF($39.2B) has a higher market cap than CING($21.1M). BEIGF YTD gains are higher at: 13.766 vs. CING (-23.124). BEIGF has higher annual earnings (EBITDA): 89.3M vs. CING (-15.75M). BEIGF has more cash in the bank: 2.76B vs. CING (9.52M). CING has less debt than BEIGF: CING (5.08M) vs BEIGF (1.03B). BEIGF has higher revenues than CING: BEIGF (4.56B) vs CING (0).
BEIGFCINGBEIGF / CING
Capitalization39.2B21.1M185,782%
EBITDA89.3M-15.75M-567%
Gain YTD13.766-23.124-60%
P/E RatioN/A0.03-
Revenue4.56B0-
Total Cash2.76B9.52M28,953%
Total Debt1.03B5.08M20,189%
TECHNICAL ANALYSIS
Technical Analysis
BEIGFCING
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
21%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
12%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CING
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IONR3.350.15
+4.69%
ioneer Ltd
VNCE1.540.03
+2.03%
VINCE HOLDING Corp
KMB129.171.17
+0.91%
Kimberly-Clark Corp
FVRR23.40N/A
N/A
Fiverr International Ltd
WK76.05-1.73
-2.22%
Workiva

BEIGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEIGF has been loosely correlated with ALZN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BEIGF jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEIGF
1D Price
Change %
BEIGF100%
N/A
ALZN - BEIGF
37%
Loosely correlated
-3.81%
NCNA - BEIGF
29%
Poorly correlated
-5.92%
CING - BEIGF
28%
Poorly correlated
+2.43%
GNTA - BEIGF
28%
Poorly correlated
-1.96%
GOVX - BEIGF
26%
Poorly correlated
-1.10%
More

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with ABCL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
+2.43%
ABCL - CING
34%
Loosely correlated
+4.26%
XRTX - CING
28%
Poorly correlated
-2.41%
BEIGF - CING
28%
Poorly correlated
N/A
LQDA - CING
26%
Poorly correlated
-1.30%
RXRX - CING
26%
Poorly correlated
-2.38%
More